Alexium International Group Ltd (ASX: AJX) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Alexium International Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.18 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.56 billion
Earnings per share -0.004
Dividend per share N/A
Year To Date Return -21.43%
Earnings Yield N/A
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Alexium International Group Ltd (ASX: AJX)
    Latest News

    man grimaces next to falling stock graph
    ⏸️ ASX Shares

    What's going on with the Alexium (ASX:AJX) share price?

    The specialty chemicals group has today given an insight into its trading halt

    Read more »

    Child with superhero mask and cape flies after jumping on sofa
    Share Gainers

    Alexium (ASX:AJX) share price rockets 34% on sales update

    Shares in the textiles producer have been surging but are currently in a pause in trading...

    Read more »

    child in superman outfit pointing skyward, indicating a rising share price
    Share Market News

    Here's why the Alexium (ASX:AJX) share price surged 9% today

    The advanced materials company has big things in store in FY22.

    Read more »

    a woman
    Share Gainers

    Why the Alexium share price is up 25% this week

    The Alexium share price has soared higher following the announcement of an exclusive development agreement.

    Read more »

    a woman
    Share Gainers

    These small cap ASX shares have started the week on a high

    The Food Revolution Group Ltd (ASX:FOD) share price is one of three at the small end of the market starting…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares started the week in the red

    The Retail Food Group Limited (ASX:RFG) share price is one of four starting the week in the red. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Why shares of Alexium International Group Ltd are down today

    Shares in chemical development company Alexium International Group Ltd (ASX:AJX) are down 5.26% in morning trade to 36 cents following an…

    Read more »

    a woman
    ⏸️ Investing

    One investment idea for FY18 that you've probably missed

    Wondering what stock investment ideas will pay off in the new financial year? Defence technology is one area you cannot…

    Read more »

    a woman
    ⏸️ Investing

    The Alexium International Group Ltd share price is up 21% this week

    The Alexium International Group Ltd (ASX:AJX) share price has been a big mover once again. Here’s what you need to…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have posted solid gains today

    The St Barbara Ltd (ASX:SBM) share price is one of four climbing notably higher today. Here’s what you need to…

    Read more »

    a woman
    ⏸️ Investing

    Alexium International Group Ltd: A promising small-cap?

    Should you buy Alexium International Group Ltd (ASX:AJX) shares today?

    Read more »

    a woman
    ⏸️ Investing

    Why these 5 ASX shares have rocketed higher today

    Bubs Australia Ltd (ASX:BUB) has been one of the standouts on the ASX today with a massive gain. Here’s why…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Mar 2004 $0.0200 100.00% Interim 15 Apr 2004

    AJX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Alexium International Group Ltd

    Alexium International Group Ltd is engaged in the development of specialty chemicals. Its only operating segment is the development and commercialization of its proprietary flame retardant (FR) and phase change material (PCM) chemistries, cooling products for bedding, and selling its specialized chemistry to customers. Geographically, it derives a majority of its revenue from the United States and also has a presence in Australia. The company products include Alexicool and Alexiflam NF.

    AJX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    11 Jun 2024 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    07 Jun 2024 $0.01 $0.00 0.00% 542,866 $0.01 $0.01 $0.01
    06 Jun 2024 $0.01 $0.00 0.00% 300,000 $0.01 $0.01 $0.01
    05 Jun 2024 $0.01 $0.00 0.00% 1,484,908 $0.01 $0.01 $0.01
    04 Jun 2024 $0.01 $0.00 0.00% 104,194 $0.01 $0.01 $0.01
    03 Jun 2024 $0.01 $0.00 0.00% 269,881 $0.01 $0.01 $0.01
    31 May 2024 $0.01 $0.00 0.00% 445,744 $0.01 $0.01 $0.01
    30 May 2024 $0.01 $0.00 0.00% 9,091 $0.01 $0.01 $0.01
    29 May 2024 $0.01 $0.00 0.00% 58,392 $0.01 $0.01 $0.01
    28 May 2024 $0.01 $0.00 0.00% 102,067 $0.01 $0.01 $0.01
    27 May 2024 $0.01 $0.00 0.00% 52 $0.01 $0.01 $0.01
    24 May 2024 $0.01 $0.00 0.00% 838,716 $0.01 $0.01 $0.01
    22 May 2024 $0.01 $0.00 0.00% 338,385 $0.01 $0.01 $0.01
    21 May 2024 $0.01 $0.00 0.00% 715,601 $0.01 $0.01 $0.01
    20 May 2024 $0.01 $0.00 0.00% 40,174 $0.01 $0.01 $0.01
    16 May 2024 $0.01 $0.00 0.00% 94,000 $0.01 $0.01 $0.01
    15 May 2024 $0.01 $0.00 0.00% 74,979 $0.01 $0.01 $0.01
    14 May 2024 $0.01 $0.00 0.00% 658,858 $0.01 $0.01 $0.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 May 2024 Simon Moore Issued 4,184,624 $46,030
    Director remuneration.
    08 May 2024 Simon Moore Buy 549,306,692 $8,239,600
    Conversion of convertible notes.
    07 May 2024 Simon Moore Issued 19,939,214 $259,209
    07 May 2024 Carl Dennis Issued 14,954,410 $94,407
    Placement. As per announcement on 09-05-2024
    06 May 2024 Carl Dennis Issued 100,430,205 $1,305,592
    Rights issue.
    06 May 2024 Carl Dennis Issued 171,144 $2,224
    Rights issue.
    06 May 2024 Simon Moore Issued 133,906,940 $1,740,790
    Rights issue.
    03 May 2024 Robert (Bob) Brookins Issued 3,850,000 $50,050
    Placement. As per announcement on 03-05-2024
    03 May 2024 Paul Stenson Issued 11,500,000 $149,500
    03 May 2024 William (Billy) Blackburn Issued 12,000,000 $156,000
    12 Jan 2024 William (Billy) Blackburn Issued 6,712,233 $93,971
    Issue of securities. 29,555,881 Share Appreciation Rights
    12 Jan 2024 Robert (Bob) Brookins Issued 6,505,703 $91,079
    Issue of securities. 19,882,851 Share Appreciation Rights
    29 Sep 2023 Rosheen Garnon Issued 3,853,481 $66,279
    Director remuneration. Estimated value
    29 Sep 2023 Simon Moore Issued 3,013,895 $51,838
    Director remuneration. Estimated value

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Simon Colinton Moore Non-Executive DirectorInterim Chairman Feb 2020
    Mr Moore is the Senior Partner of the investment firm, Colinton Capital Partners. Prior to establishing Colinton Capital Partners in 2017, Mr Moore was a Global Partner of The Carlyle Group having established their operation in Australia in 2005. In his time at The Carlyle Group, he oversaw the Firm's investments in and served on the Boards of Directors of Coates Hire, Healthscope and Qube. Mr Moore is currently Chair of the Audit Committee and a member of the Risk Committees.
    Dr Robert (Bob) Brookins Executive Director May 2018
    Dr Brookins has more than 15 years of experience in organic synthesis and materials chemistry. Upon completion of his PhD, he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed synthetic routes for reactive and functional surfaces. In 2010, Dr Brookins joined Alexium where he and his team pioneered new classes of flame-retardants for textile markets. Additionally, his research focuses on phase change materials, particularly application methods and analytical tools.
    Dr Paul Henry Stenson Non-Executive Director Jun 2020
    Dr Stenson is the chair of the Risk Committee. Dr Stenson has a career with the research, development, manufacture, and commercialisation of new materials in the fields of coatings, adhesives, nonwovens, and pharmaceuticals.
    Mr Carl Bradley Dennis Non-Executive Director Sep 2021
    Mr Dennis is an operational management professional with over 25 years of experience with expertise in Consumer and Pharmaceutical Goods. As a former CEO and commercial director, Mr Dennis has skills in new product development, sales and marketing, international brand management and operational execution. Mr Dennis was the CEO and co-owner of Vital Merchandising Services Pty Ltd for 11 years which was acquired by Imperial Logistics Limited in 2007 and he went on to hold both operational and business development C-suite roles with Imperial Logistics as part of the DP World Group. Throughout his career, his clients have included Blue Chip FMCG organisations with global brands. Over the past seven years Mr Dennis has focused on creating new markets for international Australian consumer brands across Asia, the Middle East, and Africa.
    Mr William (Billy) Timothy Blackburn Chief Executive OfficerManaging Director Sep 2022
    Mr Blackburn has over 25-years of experience in general management, with record of driving commercial growth. He has enjoyed accomplishment as both an entrepreneur and as an executive in organizations. He founded Emes, a technology-based specialty chemical business. Emes had a business model focused on chemical production paired with recycling in the pharmaceutical and consumer healthcare markets. Mr. Blackburn sold the business to Nova Molecular. He joined their executive team to lead further commercial growth of the merged organisations.
    Mr Mark Andrew Licciardo Company Secretary Mar 2020
    Jason Lewis Chief Financial Officer
    Robert Brookins Chief Technology Officer
    Mark Andrew Licciardo Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Colinton Capital Partners Pty Ltd <Colinton Cp Fund 1 (A) A/C> 79,151,331 12.15%
    Sandhurst Trustees Ltd <Wentworth Williamson A/C> 55,188,743 8.47%
    Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips Pens F A/C> 43,725,000 6.71%
    Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips S/F A/C> 30,800,000 4.73%
    BNP Paribas Nominees Pty Ltd ACF Clearstream 24,767,436 3.80%
    Dr Elyse Jane Phillips 10,475,000 1.61%
    Hsbc Custody Nominees (Australia) Limited <Gsco Customers A/C> 10,000,000 1.54%
    N & G Td Proprietary Limited <N & G Td Super Fund A/C> 10,000,000 1.54%
    Ducky'S Lifeline Pty Ltd <The R Edwards Super A/C> 8,320,552 1.28%
    Bnp Paribas Noms Pty Ltd <Drp> 8,314,657 1.28%
    Lucky Pom Pty Limited <Grayson A/C> 8,000,000 1.23%
    Citicorp Nominees Pty Limited 6,644,867 1.02%
    Mabeth Pty Ltd 6,000,000 0.92%
    Mr Ian Morton & Mrs Deborah Morton <Debian Super Fund A/C> 5,673,285 0.87%
    Mr Martin Keith Thomas & Mrs Helen Patricia Thomas 5,431,500 0.83%
    Lomand Services Limited 5,081,500 0.78%
    D & M Mowbray Holdings Pty Ltd 5,000,000 0.77%
    Rosheen Garnon 4,676,724 0.72%
    Cannow Pty Ltd <C & T Family S/Fund A/C> 4,400,000 0.68%
    Ms Frances Elizabeth Phillips & Mr Stuart Lloyd Phillips <Francesphillipssuperfnd A/C> 3,903,000 0.60%
    Radell Pty Limited <The Mackay Family Super A/C> 3,500,000 0.54%